模块化双动髋臼对年轻活跃全髋关节置换患者是否可行
前瞻性研究纳入43例年轻活跃(18-65岁、BMI<35、UCLA评分>6)初次全髋关节置换患者,使用模块化双动髋臼与无骨水泥锥形股骨柄;Harris髋关节评分从54.1改善至91.2,无脱位或再干预,但4例(9.3%)术后2年钴水平超出参考范围,作者认为需继续监测。
要点
- 年轻活跃患者使用模块化双动髋臼,2年Harris髋关节评分从54.1改善至91.2(p<0.001),无脱位或再干预。
- 平均钴水平从术前0.065 μg/l升至术后1年0.30 μg/l(p=0.01),术后2年降至0.16 μg/l(p=0.2)。
- 术后2年4例(9.3%)钴水平超出参考范围(0.03-0.29 μg/l),值为0.32-0.94 μg/l。
核心结论
- 模块化双动假体与无骨水泥锥形股骨柄在年轻活跃初次全髋关节置换患者中显示出令人鼓舞的结果。
- 平均钴水平升高及术后2年4例超出参考范围表明该队列需要继续监测。
研究设计与样本
- 前瞻性研究,纳入18至65岁、BMI<35 kg/m²、UCLA活动评分>6的初次全髋关节置换患者。
- 共43例(30男,13女;平均年龄52.6岁,sd 6.5),排除有肾病病史及身体其他部位有金属硬件者。
- 所有患者至少随访2年,在基线、术后1年和2年测量患者报告结局、全血金属离子水平(μg/l)和股骨假体周围骨密度。
- 功效分析表明需40例患者以证明钴水平较基线增加五倍(α=0.05,β=0.80),采用重复测量混合模型进行统计分析。
主要发现
- 平均Harris髋关节评分从54.1(sd 20.5)改善至术后2年91.2(sd 10.8)(p<0.001)。
- 所有患者影像学显示假体固定良好,无患者出现不稳定,无患者需要进一步干预。
- 平均钴水平从术前0.065 μg/l(sd 0.03)升至术后1年0.30 μg/l(sd 0.51)(p=0.01),术后2年降至0.16 μg/l(sd 0.23;p=0.2)。
- 术后2年4例(9.3%)钴水平超出参考范围(0.03 μg/l至0.29 μg/l),值为0.32 μg/l至0.94 μg/l。
- 使用该股骨柄设计,术后1年和2年Gruen 2至7区平均股骨骨密度比值得以维持;术后2年内侧股骨距平均骨密度为基线值的101.5%。
临床怎么用
- 作者认为,模块化双动假体与无骨水泥锥形股骨柄在年轻活跃初次全髋关节置换患者中显示出令人鼓舞的结果。
- 作者指出,平均钴水平升高及术后2年4例超出参考范围表明该队列需要继续监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Modular dual mobility (DM) prostheses in which a cobalt-chromium liner is inserted into a titanium acetabular shell ( vs a monoblock acetabular component) have the advantage of allowing supplementary screw fixation, but the potential for corrosion between the liner and acetabulum has raised concerns. While DM prostheses have shown improved stability in patients deemed 'high-risk' for dislocation undergoing total hip arthroplasty (THA), their performance in young, active patients has not been reported. This study's purpose was to assess clinical outcomes, metal ion levels, and periprosthetic femoral bone mineral density (BMD) in young, active patients receiving a modular DM acetabulum and recently introduced titanium, proximally coated, tapered femoral stem design. PATIENTS AND METHODS: This was a prospective study of patients between 18 and 65 years of age, with a body mass index (BMI) < 35 kg/m2 and University of California at Los Angeles (UCLA) activity score > 6, who received a modular cobalt-chromium acetabular liner, highly crosslinked polyethylene mobile bearing, and cementless titanium femoral stem for their primary THA. Patients with a history of renal disease and metal hardware elsewhere in the body were excluded. A total of 43 patients (30 male, 13 female; mean age 52.6 years (sd 6.5)) were enrolled. All patients had a minimum of two years' clinical follow-up. Patient-reported outcome measures, whole blood metal ion levels (ug/l), and periprosthetic femoral BMD were measured at baseline, as well as at one and two years postoperatively. Power analysis indicated 40 patients necessary to demonstrate a five-fold increase in cobalt levels from baseline (alpha = 0.05, beta = 0.80). A mixed model with repeated measures was used for statistical analysis. RESULTS: Mean Harris Hip Scores improved from 54.1 (sd 20.5) to 91.2 (sd 10.8) at two years postoperatively (p < 0.001). All patients had radiologically well-fixed components, no patients experienced any instability, and no patients required any further intervention. Mean cobalt levels increased from 0.065 ug/l (sd 0.03) preoperatively to 0.30 ug/l (sd 0.51) at one year postoperatively (p = 0.01) but decreased at two years postoperatively to 0.16 ug/l (sd 0.23; p = 0.2). Four patients (9.3%) had a cobalt level outside the reference range (0.03 ug/l to 0.29 ug/l) at two years postoperatively, with values from 0.32 ug/l to 0.94 ug/l. The mean femoral BMD ratio was maintained in Gruen zones 2 to 7 at both one and two years postoperatively using this stem design. At two years postoperatively, mean BMD in the medial calcar was 101.5% of the baseline value. CONCLUSION: Use of a modular DM prosthesis and cementless, tapered femoral stem has shown encouraging results in young, active patients undergoing primary THA. Elevation in mean cobalt levels and the presence of four patients outside the reference range at two years postoperatively demonstrates the necessity of continued surveillance in this cohort. Cite this article: Bone Joint J 2019;101-B:365-371.
引用
- Nam D, Salih R, Nahhas CR, et al. Is a modular dual mobility acetabulum a viable option for the young, active total hip arthroplasty patient? Bone Joint J. 2019. PMID: 30929489. doi:10.1302/0301-620X.101B4.BJJ-2018-0834.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。